23 November 2018
Biome Technologies plc
("Biome", "the Company" or "the Group")
Biome to present at Mello London
Biome Technologies plc (AIM: BIOM), a leading bioplastics and radio frequency technology business, is pleased to announce that the Company will be presenting at the Mello London investor conference on Tuesday 27 November 2018 to be held at the Clayton Hotel Chiswick, Chiswick High Road, London, W4 5RY.
For further information on the Mello London conference, please visit the event website at http://melloevents.com/mello-london/.
- Ends -
For further information please contact: Biome Technologies plc |
|
Paul Mines, Chief Executive Officer |
|
Declan Brown, Group Finance Director |
|
www.biometechnologiesplc.com |
Tel: +44 (0) 2380 867 100 |
Allenby Capital |
|
David Hart/Alex Brearley (Nominated Adviser) Kelly Gardiner (Broker) |
|
www.allenbycapital.com |
Tel: +44 (0) 20 3328 5656 |
|
|
|
|
About Biome
Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and that are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.
The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited. Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers. Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.
In 2018, the Board has adopted the following three high level KPIs for the next three years to continue its ambitious momentum:
· Compound revenue growth of 25% per annum across the Group and 40% compound revenue growth in the Bioplastics division
· Diversify the Group's turnover by product and market to ensure that no one product or end customer contributes more than 15% of revenues by 2020
· Increase investment in the Group's next generation of products by spending significantly more per annum on average than the £0.3m per annum average spend over the previous strategic objective cycle